High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer

Class III β-tubulin (βIII-tubulin) has been associated with tumor response to taxane-based therapies in breast cancer. However its role in the neoadjuvant setting has not been explored. We evaluated βIII-tubulin expression by immunohistochemistry in 44 patients, and found high expression associated...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wang, Yihong, Sparano, Joseph A., Fineberg, Susan, Stead, Lesley, Sunkara, Jaya, Horwitz, Susan Band, McDaid, Hayley M.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039021/
https://ncbi.nlm.nih.gov/pubmed/23218766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2012.11.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires